Skip to main content
. 2021 Jul 26;13(7):795–824. doi: 10.4252/wjsc.v13.i7.795

Figure 1.

Figure 1

Regulatory mechanism of programmed death-1/programmed death ligand 1 signaling in cancer. The interaction between programmed death-1 and programmed death ligand 1 (PD-L1) leads to the inhibition of T cell functional activation. PD-L1 expression in cancer cells is regulated by aberrant oncogenic pathways. PD-1: Programmed death-1; PD-L1: Programmed death ligand 1; TCR: T cell receptor; ITSM: Immunoreceptor tyrosine-based switch motif; ITIM: Immunoreceptor tyrosine-based inhibitory motif; IRF: Interferon regulatory factor.